
Zosano Pharma (ZSAN) Earnings Dates & Reports
Zosano Pharma (ZSAN) Most Recent Earnings
Report Date
Period EndingQ4 2021
Est. EPS-$1.40
Actual EPS-$2.10
EarningsMiss
Zosano Pharma (ZSAN) Earnings
View the latest Zosano Pharma (ZSAN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Zosano Pharma (ZSAN)
Order type
Buy in
Order amount
Est. shares
0 shares
Zosano Pharma (ZSAN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Zosano Pharma (ZSAN) Latest Earnings
The value each ZSAN share was expected to gain vs. the value each share gained.
Zosano Pharma (ZSAN) reported its most recent earnings on for Q4 2021, posting earnings per share (EPS) of -$2.10. This exceeded analysts' expectations of -$1.40 by 50.00%, marking a Miss.
For comparison, Zosano Pharma reported EPS of -$2.80 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Zosano Pharma (ZSAN) Earnings History
Zosano Pharma (ZSAN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Zosano Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Zosano Pharma (ZSAN) Earnings FAQs
Zosano Pharma (ZSAN) last reported earnings on Mar 17, 2022 for Q4 2021, posting an EPS of -$2.10, which Miss the estimate of -$1.40 by 50.00%.
For Q4 2021, Zosano Pharma (ZSAN) reported an EPS of -$2.10, missing analysts' estimate of -$1.40 by 50.00%.
For Q4 2021, Zosano Pharma (ZSAN) Miss expectations with an actual EPS of -$2.10 vs. an estimated EPS of -$1.40.
Following the last earnings report on Mar 17, 2022, Zosano Pharma (ZSAN)'s stock price moved — from — to —.
The next Zosano Pharma (ZSAN) earnings call is scheduled for Mar. 17, 2022, where executives will discuss financial results and outlook.